DK0471761T3 - Anvendelse af en GnRH-analog til fremstilling af et lægemiddel til behandling af bevægelsesforstyrrelser - Google Patents

Anvendelse af en GnRH-analog til fremstilling af et lægemiddel til behandling af bevægelsesforstyrrelser

Info

Publication number
DK0471761T3
DK0471761T3 DK90907817.2T DK90907817T DK0471761T3 DK 0471761 T3 DK0471761 T3 DK 0471761T3 DK 90907817 T DK90907817 T DK 90907817T DK 0471761 T3 DK0471761 T3 DK 0471761T3
Authority
DK
Denmark
Prior art keywords
treatment
drug
manufacture
movement disorders
gnrh analog
Prior art date
Application number
DK90907817.2T
Other languages
Danish (da)
English (en)
Inventor
John R Mathias
Original Assignee
John R Mathias
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John R Mathias filed Critical John R Mathias
Application granted granted Critical
Publication of DK0471761T3 publication Critical patent/DK0471761T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK90907817.2T 1989-05-09 1990-05-03 Anvendelse af en GnRH-analog til fremstilling af et lægemiddel til behandling af bevægelsesforstyrrelser DK0471761T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/349,717 US5068221A (en) 1989-05-09 1989-05-09 Treatment of motility disorders with a gnrh analog

Publications (1)

Publication Number Publication Date
DK0471761T3 true DK0471761T3 (da) 1994-09-19

Family

ID=23373648

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90907817.2T DK0471761T3 (da) 1989-05-09 1990-05-03 Anvendelse af en GnRH-analog til fremstilling af et lægemiddel til behandling af bevægelsesforstyrrelser

Country Status (13)

Country Link
US (1) US5068221A (ko)
EP (1) EP0471761B1 (ko)
JP (1) JPH04505016A (ko)
KR (1) KR920700676A (ko)
AT (1) ATE110277T1 (ko)
AU (2) AU628763B2 (ko)
CA (1) CA2053880C (ko)
DE (1) DE69011857T2 (ko)
DK (1) DK0471761T3 (ko)
ES (1) ES2057565T3 (ko)
IL (1) IL94330A (ko)
NZ (1) NZ248242A (ko)
WO (1) WO1990013308A1 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5434136A (en) * 1990-12-14 1995-07-18 Mathias; John R. Treatment of motility disorders with a GNRH analog
US5470847A (en) * 1993-12-10 1995-11-28 Board Of Regents, The University Of Texas System Ovulation control by regulating nitric oxide levels with arginine derivatives
KR100440643B1 (ko) * 1999-01-28 2004-07-21 쥬가이 세이야쿠 가부시키가이샤 치환 페네틸아민 유도체
WO2004100882A2 (en) * 2003-05-06 2004-11-25 Syntonix Pharmaceuticals, Inc. Inhibition of drug binding to serum albumin
AU2019377858B2 (en) * 2018-11-09 2022-03-17 Ims Trading, Llc Edible pet chews and methods of forming the same

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO139560C (no) * 1972-04-29 1979-04-04 Takeda Chemical Industries Ltd Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
CA1009230A (en) * 1972-09-26 1977-04-26 Daiichi Seiyaku Co. Peptides effecting to the release of sex hormones and a method for preparing the same
JPS563846B2 (ko) * 1972-10-12 1981-01-27
CS180644B2 (en) * 1973-09-29 1978-01-31 Takeda Chemical Industries Ltd Process for preparing nonapeptides
US3914412A (en) * 1973-10-11 1975-10-21 Abbott Lab {8 Des{13 Gly{9 {0 10 -Gn{13 RH nonapeptide amide analogs in position 6 having ovulation-inducing activity
US4005063A (en) * 1973-10-11 1977-01-25 Abbott Laboratories [Des-gly]10 -GnRH nonapeptide anide analogs in position 6 having ovulation-inducing activity
US4072668A (en) * 1973-11-06 1978-02-07 The Salk Institute For Biological Studies LH-RH Analogs
US4552764A (en) * 1974-11-14 1985-11-12 Research Corporation Peptides for control of intestinal motility
US4010261A (en) * 1974-11-25 1977-03-01 Abbott Laboratories Method to prevent reproduction with [Des-Gly]10 -GN-RH nonadeptide amide analogs in position
US4002738A (en) * 1975-05-30 1977-01-11 Abbott Laboratories Treatment of specified neoplasias
US4005194A (en) * 1975-06-23 1977-01-25 Abbott Laboratories Treatment of prostatic hyperplasia
US4018914A (en) * 1975-11-13 1977-04-19 Abbott Laboratories Parturition inducement
JPS54148722A (en) * 1978-05-12 1979-11-21 Takeda Chem Ind Ltd Nonapeptide and its preparation
FR2465486A1 (fr) * 1979-09-21 1981-03-27 Roussel Uclaf Nouvelle application utilisant la lh-rh ou des agonistes
US4409208A (en) * 1980-04-15 1983-10-11 The Salk Institute For Biological Studies GnRH antagonists
US4410514A (en) * 1982-12-06 1983-10-18 The Salk Institute For Biological Studies GnRH Agonists
US4619914A (en) * 1983-03-10 1986-10-28 The Salk Institute For Biological Studies GNRH antagonists IIIB
US4569927A (en) * 1984-02-23 1986-02-11 The Salk Institute For Biological Studies GnRH Antagonists IV
US4652550A (en) * 1984-05-21 1987-03-24 The Salk Institute For Biological Studies GnRH antagonists VII
US4565804A (en) * 1984-09-07 1986-01-21 The Salk Institute For Biological Studies GnRH Antagonists VI
US4752577A (en) * 1984-09-13 1988-06-21 Eli Lilly And Company Method for using a novel transcriptional- and translational-activating sequence in streptomyces
US4690916A (en) * 1984-11-13 1987-09-01 Syntex (U.S.A.) Inc. Nona and decapeptide analogs of LHRH useful as LHRH antagonists
US4740500A (en) * 1985-01-31 1988-04-26 The Salk Institute For Biological Studies GnRH antagonists VIII
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
US4661472A (en) * 1985-05-09 1987-04-28 The Salk Institute For Biological Studies GnRH antagonists IX
US4920102A (en) * 1988-04-18 1990-04-24 Eli Lilly And Company Method for treating gastrointestinal disorders

Also Published As

Publication number Publication date
WO1990013308A1 (en) 1990-11-15
ES2057565T3 (es) 1994-10-16
AU5559590A (en) 1990-11-29
ATE110277T1 (de) 1994-09-15
DE69011857D1 (de) 1994-09-29
IL94330A (en) 1995-03-30
US5068221A (en) 1991-11-26
KR920700676A (ko) 1992-08-10
CA2053880C (en) 1997-01-14
AU1620392A (en) 1992-07-30
AU639403B2 (en) 1993-07-22
JPH04505016A (ja) 1992-09-03
EP0471761A4 (en) 1992-06-24
CA2053880A1 (en) 1990-11-10
NZ248242A (en) 1997-07-27
AU628763B2 (en) 1992-09-17
EP0471761B1 (en) 1994-08-24
DE69011857T2 (de) 1995-03-23
EP0471761A1 (en) 1992-02-26
IL94330A0 (en) 1991-03-10

Similar Documents

Publication Publication Date Title
FR2703254B1 (fr) Dispositif de traitement thérapeutique d'un tissu pathologique, comportant un cathéter .
DE3779500T2 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
ES2060941T3 (es) Uso de nicotina para la fabricacion de un estuche para el tratamiento de condiciones susceptibles de dicho tratamiento.
ES2107459T3 (es) Mejora de la regulacion represora de enfermedades autoinmunes por administracion oral o enteral de autoantigenos.
NL970006I1 (nl) Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson.
DK1162982T3 (da) Anvendelse af stabiliserede oligonucleotider til fremstilling af et lægemiddel med antitumoral virkning
PT97770A (pt) Metodo para o tratamento de doenca mental psicotica com uanidinas substituidas tendo elevada afinidade de ligacao ao receptor sigma
ES2061727T3 (es) Sustancias fisiologicamente activas, un procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
DK0501705T3 (da) Anvendelse af tomoxetin til behandling af sygdomme i de nedre urinveje
IT7849358A0 (it) Procedimento per la cura farmacologica dell'abitudine alla droga con alfa-metil-para-tirosina
DK0471761T3 (da) Anvendelse af en GnRH-analog til fremstilling af et lægemiddel til behandling af bevægelsesforstyrrelser
BR9712466A (pt) Aplicação de adamantanaminas ou compostos de estrutura análogo para combater o vìrus da doença de borna e para a profilaxia e tratamento de doenças emocionais e outras perturbaçoes ligadas com infecçoes do vìrus bd homem e animal
ATE81980T1 (de) Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung.
ES2051710T3 (es) Utilizacion de d-fenfluramina para la fabricacion de medicamentos para el tratamiento de depresiones.
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
EP0437929A3 (en) Use of diadenosine-5',5'''-p1,p4-tetraphosphate for the manufacture of a medicament for the treatment of heart disease
HUP0301831A2 (hu) Gepiron bioaktív metabolitjainak alkalmazása pszichológiai rendellenességek kezelésére
ES2113345T3 (es) Tratamiento de la disfuncion cardiaca con la ayuda de compuestos 15-ceto-prostaglandina.
NO881303D0 (no) Underlag for pasientseng.
DK10188D0 (da) Middel til behandling af virussygdomme
ATE398134T1 (de) Neue analoga von nitrobenzylthioinosin
HUP0004647A2 (hu) Glükóz-amino-glükánok alkalmazása diabétesszel társult szembetegségek kezelésére szolgáló gyógyszerkészítmények előállítására
KR880002525A (ko) 뇌 허혈성 병을 수반하는 질환 치료제
IT208524Z2 (it) Telo attrezzato, atto ad isolare un arto, destinato ad interventi chirurgici, di un paziente, dal tronco del paziente stesso.
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it